There are 511 resources available
452P - Prognostic analysis of pathologic complete response after neoadjuvant therapy for locally advanced gastric cancer: A nationwide, multicenter, retrospective study
Presenter: Jie Chen
Session: Poster Display session
Resources:
Abstract
453P - Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset gastric cancer: A retrospective cohort study on 18877 patients managed from 2000 to 2022 in a Chinese cancer center
Presenter: Yingxue Liu
Session: Poster Display session
Resources:
Abstract
454P - Compliance with perioperative chemotherapy improved overall survival post-radical gastrectomy & D2 lymphadenectomy in gastric cancer: Real-world evidence from a tertiary care cancer center
Presenter: Rakesh Pinninti
Session: Poster Display session
Resources:
Abstract
455P - Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer
Presenter: Wendy Chan
Session: Poster Display session
Resources:
Abstract
456P - Correlation between pathological complete response (pCR) and survival outcomes in patients with resectable esophageal (EC) or gastroesophageal junction cancer (GEJC): A large, real-world, single-center cohort analysis
Presenter: Marco Airoldi
Session: Poster Display session
Resources:
Abstract
457P - Development of absolute 5-year risk prediction model for gastric cancer and comparisons with current guideline in China: A population-based, prospective study
Presenter: Siyi He
Session: Poster Display session
Resources:
Abstract
458P - Treatability with combination chemotherapy and eligibility for addition of new drugs in all gastroesophageal cancer patients referred for medical treatment 2016-2022 at a tertiary centre serving 540.000 inhabitants
Presenter: Kaisa Lehtomaki
Session: Poster Display session
Resources:
Abstract
459P - Layer analysis based on RNA-seq data of TCGA reveals gastric cancer's molecular complexity
Presenter: Ismael Ghanem
Session: Poster Display session
Resources:
Abstract
460P - Real-world study of ramucirumab and paclitaxel as =2nd-line therapy in patients with HER2-positive gastroesophageal cancer
Presenter: Yvonne Bach
Session: Poster Display session
Resources:
Abstract
461P - Finding the minimum number of retrieved lymph nodes and negative lymph nodes in gastric cancer surgery: A large-scale retrospective study from China
Presenter: Jie Chen
Session: Poster Display session
Resources:
Abstract